TABLE 2.

Relationship between IMA and in-hospital mortality in different models.

Exposure	Crude Model (OR,95CI,P)	Model I (OR,95CI,P)	Model II (OR,95CI,P)
IMA(μ/ml)	1.12 (1.09, 1.14) < 0.001	1.12 (1.10, 1.14) < 0.001	1.10 (1.08, 1.13) < 0.001
IMA (tertile)
T1(15.2–66.2)	Ref	Ref	Ref
T2(66.3–78.2)	1.73 (0.78, 3.86) = 0.181	1.72 (0.77, 3.84) = 0.187	2.17 (0.75, 6.32) = 0.153
T3(78.3–274.5)	27.80 (14.07, 54.94) < 0.001	28.35 (14.31, 56.16) < 0.001	44.93 (16.53, 122.17) < 0.001
P for trend	<0.001	<0.001	<0.001

Model I adjusted for age, gender and BMI. Model II adjusted for age, gender, BMI, hypertension, diabetes, stroke, atherosclerosis, Marfan syndrome, CRI, smoking, symptom, Myocardial ischemia, Hb, ALT, AST, ALB, TB, DB, Cr, cTnT, CK-Mb, type of AAD (Stanford) and management. ALB, albumin; ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, body mass index; CK-Mb, creatine kinase Mb; Cr, creatinine; CRI, chronic renal insufficiency; cTnT, Troponin T; DB, direct bilirubin; DBP, diastole blood pressure; Hb, hemoglobin; IMA, ischemia-modified albumin; SBP, systolic blood pressure; TB, total bilirubin.